Navigation Links
PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
Date:9/24/2008

results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, the award of government contracts to our competitors, unforeseen safety issues, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, as well as risks detailed from time to time in PharmAthene's Form 10-K under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC"). In particular, the studies described above involving Protexia(R) and Valortim(R) constitute non-clinical animal studies. Significant additional non-clinical animal studies, human clinical trials, and manufacturing development work remain to be done under both programs. At this point there can be no assurance that either of these product candidates will be shown to be safe and effective and approved by regulatory authorities for use in humans. Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at http://www.pharmathene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
5. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
11. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... British Columbia and MENLO PARK, Calif. ... (OTCQB: DMPI) ("DelMar" "the company") announced today a protocol ... trial had been filed with the U.S. Food and Drug ... 50mg/m 2 has been opened at three clinical trial ... company also confirmed that gross proceeds of US$2.9 million have ...
(Date:8/19/2014)... August 19, 2014 According to ... (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
(Date:8/18/2014)... NAGOYA, Japan , Aug. 19, 2014 /PRNewswire/ ... and ASAHI INTECC (Securities Code 7747, Second Section, ... formalized plans to develop a new, differentiated fractional flow ... a device intended to improve handling compared to existing ... emerging field in interventional cardiology that exceeds $250 million ...
Breaking Medicine Technology:DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 2DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 3DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 4DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 5DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 6DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 2Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 3Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 4Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 5Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 6Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 7Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 8Global Surgical Navigation Systems Market to Reach USD 295.5 Million in 2020 - Report by MarketResearchReports.biz 9Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 2Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 3Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs 4
... 2010 Microfluidics International Corporation (OTC Bulletin Board: ... third quarter 2010 financial results on Tuesday, November 16, ... President and Chief Executive Officer, and Peter F. Byczko, ... host a conference call and live audio webcast. ...
... YORK, Nov. 9, 2010 Malaria No More and the ... NightWatch. Senegalese singer Youssou NDour and other international celebrities are ... celebrity voices and deliver an important nightly message about malaria. ... will use radio, television and cell phone text messaging (SMS) ...
Cached Medicine Technology:Microfluidics International Corporation to Report Third Quarter 2010 Financial Results on November 16, 2010 2World-Renowned Singer Youssou NDour Launches NightWatch Program 2
(Date:8/20/2014)... Botanica Day Spa ... the new and popular stem cell line from ... and wrinkles and naturally repairs the skin. The ... new service by offering clients a complimentary dermaplaning ... facial. , Pevonia® continues to be a global ...
(Date:8/20/2014)... of Manchester and Auckland suggest that both major forms of ... The findings, published today in the FASEB Journal ... and type-2 diabetes are both caused by the formation of ... The results, based on 20 years, work in New Zealand, ... down and potentially reversed by medicines that stop amylin forming ...
(Date:8/20/2014)... The Workgroup for Electronic Data ... the use of health IT to create efficiencies ... for its annual fall conference, WEDI-Con 2014: The ... will take place at the HYATT Regency in ... diverse cross-section of payers, providers, government regulators, industry ...
(Date:8/20/2014)... 20, 2014 The National Association ... $1.24 million Science Education Partnership Award (SEPA) grant ... NAHN’s collaborative project with the Hispanic Communications Network ... , This collaborative NIH R25 program has been ... linguistic diversity among health professionals by recruiting and ...
(Date:8/20/2014)... 20, 2014 Attendees of Seedstock’s 3rd ... peak at Los Angeles’ first multi-faceted food production business ... a blossoming 1.5-acre high school campus urban farming operation ... farm in the L.A. Art District. , The field ... urban agriculture, will kick off Seedstock’s “Reintegrating Ag: Local ...
Breaking Medicine News(10 mins):Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Scientists show type-1 and type-2 diabetes are caused by same underlying mechanism 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 2Health News:National Association of Hispanic Nurses (NAHN) Receives Five-Year Federal Grant from the National Institutes of Health (NIH) 3Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 2Health News:Seedstock Sustainable Agriculture Conference’s Urban Farm Field Trip to Offer First Look at Los Angeles’ Premier Food Business Incubator 3
... , ... entered into a multi-year software and support agreement with AAA Motor Club Holdings to provide ... of the AAA Motor Club Holdings group. , ... Atlanta GA (PRWEB) -- Ross Group Inc announced they have entered ...
... , ... Virtual Event at www.BioConferenceLive.com Features G. Steven Burrill, Funder and Supporter of Biotech ... ... leading digital media producer of free online events for the healthcare, education and energy industries, ...
... ... Centre today announced it will begin training husbands, partners, and assistants such as midwives ... ... -- The Pregnancy Health Centre today announced it will begin training husbands, partners, and ...
... ... myShoes.com , ... 18, 2010 -- myShoes.com , a new search engine just for women’s shoes ... in a woman’s lower back soften while pregnant and the right type of shoe is ...
... ... , ... Patients looking for a dentist in Lincoln, NE will have a new option for ... at 4960 O Street on Thursday, May 27. The new dental practice will provide services that ...
... Findings may lead to earlier detection and personalized therapy, ... specific grouping of three markers on the surface of ... aggressive, but relatively rare form of cancer called "estrogen ... considered to be preliminary but the identification of these ...
Cached Medicine News:Health News:Ross Group Inc Expands Sales of Membership and Customer Relationship Management Software 2Health News:Ross Group Inc Expands Sales of Membership and Customer Relationship Management Software 3Health News:BioConference Live Announces Speakers and Sponsors for Second Edition of Premier Online Conference for Life Science Community 2Health News:BioConference Live Announces Speakers and Sponsors for Second Edition of Premier Online Conference for Life Science Community 3Health News:BioConference Live Announces Speakers and Sponsors for Second Edition of Premier Online Conference for Life Science Community 4Health News:Pregnancy Health Centre Teaches Husbands, Partners and Midwives About Obstetrical Acupressure 2Health News:Pregnancy Health Centre Teaches Husbands, Partners and Midwives About Obstetrical Acupressure 3Health News:MyShoes.com, a New Search Engine for Women's Shoes, Features Chic Shoes for Expectant Mothers 2Health News:MyShoes.com, a New Search Engine for Women's Shoes, Features Chic Shoes for Expectant Mothers 3Health News:New Aspen Dental Office Opens in Lincoln, Nebraska 2Health News:New Aspen Dental Office Opens in Lincoln, Nebraska 3Health News:New Clues to Treating an Aggressive Breast Cancer 2
... Clinical Xpert™ for PDAs is a new ... Clinical Xpert puts authoritative drug, disease and ... physicians and other prescribers, nurses, pharmacists, and ... decisions at the point of care, and ...
The 3-chip MediLive Trio Eye video camera is built to adapt to changing conditions during ophthalmic surgery with features designed for workflow optimization and maximum image quality....
... A valuable new tool for ... exhibits greater dynamic range and shows ... SWAP, at the same degree of ... has been shown to correlate with ...
... The VISUCAM non-mydriatic ... quality and simplicity of ... big enough to set ... photography, it features a ...
Medicine Products: